Civic Intelligence

Frontiers in Bioscience

EIN 59-3432665 • 501(c)3 • Newport Coast, CA

Profile

Frontiers in bioscience is an organization dedicated to fostering science, research and teaching. Fbs has been involved in these activities since jan 1 1996. Fbs has published over 4000 scholarly scientific articles in medicine and biology from well known scientists. Fbs also carries research in understanding cancer since 2007 and has been working on aging reversal since 2011. Our research on cancer is geared towards understanding the reason for cancer growth and recurrence as well as understanding the cause of disturbed metabolism (warburg's effect) of cancer cells. Such an insight is significant since it provides us with new avenues for treatment of cancer or cancer cure. The treatment of cancer based, on our hypothesis, is founded on new non-chemotherapeutic and non-radiotherpay approaches. We also examine the cause of senescence, as well as approaches for reversal or deceleration of this process. Based on such a background, we will examine whether senescence can be reversed or dece

20 Sunset CoveNewport Coast, CA 92657

www.bioscience.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

25th percentile

0.02x

Higher debt load relative to assets than 25% of similar nonprofits.

501(c)3 • $5M-$10M nonprofits • Source year 2022

Liabilities / Revenue

87th percentile

1.35x

Higher debt load relative to revenue than 87% of similar nonprofits.

501(c)3 • $5M-$10M nonprofits • Source year 2022

Net Margin

3rd percentile

-109%

Higher net margin than 3% of similar nonprofits.

501(c)3 • $5M-$10M nonprofits • Source year 2022

Top Officer Pay

Score unavailable

No value available

No filing with officer rows is available for this organization yet.

Asset Growth

30th percentile

-1.0%

Faster asset growth than 30% of similar nonprofits.

501(c)3 • $5M-$10M nonprofits • Annualized from 2021 to 2022

Revenue Growth

4th percentile

-54%

Faster revenue growth than 4% of similar nonprofits.

501(c)3 • $5M-$10M nonprofits • Annualized from 2021 to 2022

Balance Sheet
Liabilities / Assets25th percentile

Assets

Down

$8,977,418

Down $169,841 (-1.9%) from 2024

Liabilities

Up

$246,462

Up $2,414 (+1.0%) from 2024

Net Assets

Down

$8,730,956

Down $172,255 (-1.9%) from 2024

Operations
Liabilities / Revenue87th percentileNet Margin3rd percentile

Revenue

Up

$179,746

Up $20,563 (+13%) from 2024

Expenses

Up

$394,681

Up $60,130 (+18%) from 2024

Net Income

Down

-$214,935

Down $39,567 (-23%) from 2024

Trend Graphs

Balance Sheet Trend

Asset Growth30th percentile

Grouped bars show assets, liabilities, and net assets across loaded filings.

$10M$5.0M$0Assets 2011: $6,072,390Liabilities 2011: $145,555Net Assets 2011: $5,926,8352011Assets 2012: $6,593,702Liabilities 2012: $161,267Net Assets 2012: $6,432,4352012Assets 2013: $7,019,430Liabilities 2013: $158,293Net Assets 2013: $6,861,1372013Assets 2014: $7,380,585Liabilities 2014: $279,146Net Assets 2014: $7,101,4392014Assets 2015: $7,717,237Liabilities 2015: $161,947Net Assets 2015: $7,555,2902015Assets 2016: $7,719,461Liabilities 2016: $139,799Net Assets 2016: $7,579,6622016Assets 2017: $7,939,484Liabilities 2017: $38,338Net Assets 2017: $7,901,1462017Assets 2018: $8,152,585Liabilities 2018: $31,140Net Assets 2018: $8,121,4452018Assets 2019: $8,329,196Liabilities 2019: $28,843Net Assets 2019: $8,300,3532019Assets 2020: $9,154,107Liabilities 2020: $192,253Net Assets 2020: $8,961,8542020Assets 2021: $9,263,668Liabilities 2021: $187,520Net Assets 2021: $9,076,1482021Assets 2022: $9,068,473Liabilities 2022: $175,870Net Assets 2022: $8,892,6032022Assets 2023: $9,132,862Liabilities 2023: $252,072Net Assets 2023: $8,880,7902023Assets 2024: $9,147,259Liabilities 2024: $244,048Net Assets 2024: $8,903,2112024Assets 2025: $8,977,418Liabilities 2025: $246,462Net Assets 2025: $8,730,9562025

Highlighted filing

2025

Assets$8,977,418
Liabilities$246,462
Net Assets$8,730,956
Open 2025 Filing

Operations Trend

Revenue Growth4th percentile

Revenue, expenses, and net income by year, with the latest filing highlighted.

$1.5M$1.0M$500K$0-$500KExpenses 2011: $303,3232011Expenses 2012: $566,8742012Revenue 2013: $1,020,368Expenses 2013: $591,666Net Income 2013: $428,7022013Revenue 2014: $929,379Expenses 2014: $583,280Net Income 2014: $346,0992014Revenue 2015: $959,466Expenses 2015: $568,606Net Income 2015: $390,8602015Revenue 2016: $686,860Expenses 2016: $662,488Net Income 2016: $24,3722016Revenue 2017: $884,845Expenses 2017: $563,361Net Income 2017: $321,4842017Revenue 2018: $687,687Expenses 2018: $467,385Net Income 2018: $220,3022018Revenue 2019: $665,550Expenses 2019: $464,587Net Income 2019: $200,9632019Revenue 2020: $1,172,136Expenses 2020: $303,230Net Income 2020: $868,9062020Revenue 2021: $287,321Expenses 2021: $239,359Net Income 2021: $47,9622021Revenue 2022: $130,196Expenses 2022: $272,103Net Income 2022: -$141,9072022Revenue 2023: $252,831Expenses 2023: $264,644Net Income 2023: -$11,8132023Revenue 2024: $159,183Expenses 2024: $334,551Net Income 2024: -$175,3682024Revenue 2025: $179,746Expenses 2025: $394,681Net Income 2025: -$214,9352025

Highlighted filing

2025

Revenue$179,746
Expenses$394,681
Net Income-$214,935
Open 2025 Filing

Filings

Most recent year

2025 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$8,977,418
Liabilities
$246,462
Net assets
$8,730,956
Revenue
$179,746
Expenses
$394,681
Net income
-$214,935
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2025Detailed filing. Detailed filing data is available for this year.$8.98$0.25$8.73$0.18$0.39$0.21
2024XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.15$0.24$8.90$0.16$0.33$0.18
2023XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.13$0.25$8.88$0.25$0.26$0.01
2022XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.07$0.18$8.89$0.13$0.27$0.14
2021XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.26$0.19$9.08$0.29$0.24$0.05
2020XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.15$0.19$8.96$1.17$0.30$0.87
2019XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$8.33$0.03$8.30$0.67$0.46$0.20
2018XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$8.15$0.03$8.12$0.69$0.47$0.22
2017XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$7.94$0.04$7.90$0.88$0.56$0.32
2016XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$7.72$0.14$7.58$0.69$0.66$0.02
2015Detailed filing. Detailed filing data is available for this year.$7.72$0.16$7.56$0.96$0.57$0.39
2014Detailed filing. Detailed filing data is available for this year.$7.38$0.28$7.10$0.93$0.58$0.35
2013XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$7.02$0.16$6.86$1.02$0.59$0.43
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$6.59$0.16$6.43$0.57
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$6.07$0.15$5.93$0.30
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2025 to Dec 31, 2025
Signed
Jan 16, 2026
Return Version
2025v4.0
Gross Receipts
$316,523
Mission and Program Overview

Mission

Frontiers in bioscience ia an organizatioj dedicated to fostering science, research and teaching. Fbs has been invo;ve in these activities since jan. 1 1996. Fbs has published ober 4000 scholarly scientific articles in medicine and biology from well known scientists. Fbs also carries research in understanding cancer since 2007 and has been working on aging reversal since 2011. Our research on cancer is geared towards understanding the reason for cancer growth and reurranxce as well as understanding the cause of disturbed metabolism of cancer cells in order to gain an insight to provide new avenues for treatment. We use stem cells as well as signaling molecules to acheive the therapeutic end.

Balance Sheet Detail
LineBeginningEndChange
Assets
Land, Buildings, and Equipment, Net$5,810,376$5,701,157▼ $109,219
Savings and Temporary Cash Investments$3,146,321$3,179,571▲ $33,250
Loans From Officers Directors$233,187$233,187→ $0
Cash and Non-Interest-Bearing Accounts$137,036$86,834▼ $50,202
Investments in Publicly Traded Securities$5,481$5,484▲ $3
Prepaid Expenses and Deferred Charges$6,045$4,372▼ $1,673
Total Assets$9,147,259$8,977,418▼ $169,841
Other Assets Total$42,000--
Liabilities
Other Liabilities$10,861$13,275▲ $2,414
Total Liabilities$244,048$246,462▲ $2,414
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$8,903,211$8,730,956▼ $172,255
Total Net Assets Fund Balance$8,903,211$8,730,956▼ $172,255
Total Liabilities and Net Assets / Fund Balance$9,147,259$8,977,418▼ $169,841

Asset Categories

AssetBook ValueDepreciationBasis
Buildings$2,496,646$1,006,507$3,503,153
Land$3,229,805-$3,229,805
Other Land Buildings$-25,294$439,835$414,541
Compensation and Service Providers
Top Officer PayScore unavailable

Board Members and Trustees

NameTitle
Siamak Tabibzadeh MdCEO
Shila RoofimCFO
Forough SooferianSec
Revenue and Support

Revenue Composition

Contributions and Grants
$0
Program Service Revenue
$0
Investment Income
$48,570
Other Revenue
$131,176
Change in Net Assets
$-214,935
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$227,519
Salaries, Compensation, and Employee Benefits$167,162
Total Fundraising Expense$9,566
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Comp Disqual Persons$70,400$8,800$8,800$88,000
Other Salaries and Wages$66,922--$66,922
Depreciation Depletion$54,671--$54,671
All Other Expenses$17,339$8,522-$25,861
Other Expenses$12,870$21,996-$12,870
Payroll Taxes$10,708$766$766$12,240
Fees for Services Accounting$950--$950
Fees for Services Legal-$695-$695
Interest-$211-$211
Insurance$90--$90
Total Functional Expenses$279,531$105,584$9,566$394,681
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Insider Transactions and Loans

Loans and Receivables

Line ItemBeginningEndChange
Loans from Officers, Directors, Trustees, and Key Employees$233,187$233,187→ $0
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Tenant Deposits$8,290
Credit Card/ Payroll Taxes$4,985
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Backup withholding compliance
No
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
No
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Page 6, Part VI, Line 11B

“No review was or will be conducted.”

Form 990, Page 6, Part VI, Line 19

“No documents available to the public”

Filing and Contact Details

Filer

Filer Name
Frontiers in Bioscience
EIN
59-3432665
Phone
9497158286
Address
20 SUNSET COVE, NEWPORT COAST, CA 92657

Signing Officer

Name
Siamak Tabibzadeh Md
Title
CEO
Phone
9497158286
Signed
2026-01-16
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Siamak Tabibzadeh Md
Voting Board Members
3
Independent Board Members
0
Employees
3

Preparer

Firm
Lgh Consulting Inc
Address
585 S STATE COLLEGE BLVD, ANAHEIM, CA 92806-4222
Preparer
George Hukriede
Phone
7148089170
Supplemental Narrative

Additional Explanations

FORM 990 - ORGANIZATION'S MISSION

“Frontiers in bioscience ia an organizatioj dedicated to fostering science, research and teaching. Fbs has been invo;ve in these activities since jan. 1 1996. Fbs has published ober 4000 scholarly scientific articles in medicine and biology from well known scientists. Fbs also carries research in understanding cancer since 2007 and has been working on aging reversal since 2011. Our research on cancer is geared towards understanding the reason for cancer growth and reurranxce as well as understanding the cause of disturbed metabolism of cancer cells in order to gain an insight to provide new avenues for treatment. We use stem cells as well as signaling molecules to acheive the therapeutic end.”

Form 990

“See attachment november 20, 2022 part iv, line 63, loans from officers, director and employee on november 20, 2002, frontiers in bioscience, inc. Purchased for investment purposes only residential real estate located at 67 parkview drive, searingtown, new york. In connection with the organization's purchase of said real estate, frontiers in bioscience inc., incurred a mortgage payable with the presiden and founder, siamak tabibzadeh, md, in the amount of 145,000 lender's name: siamak tabibzadeh, md original amount of note: 154,000 balance due: 145,555 date of note: november 20, 2002 maturity date: open, see below repayment terms: principal and accrued interest due upon sale of property interest rete: rate of 4.5% per annum, principal and interest due upon sale of property or at such time as the board of director determines that there are sufficient operating funds to retire the obiligation security priovided by the borrower: mortgage note secured by real estate located at 67 parkview drive, searingtown, ny 11507 purpose of the loan: to be able to purchase real estate at below fair market value to see in no longer than two operating cycles in order to obtain sufficient funding to endow a full time medical researcher and editor. Interst calcuation original amount of principal: 154,000 from to interest amount (rate, 4.5%) - principal + interest nov 20, 2002 154,000 nov 20, 2002 nov 20, 2003 6,930 - 160,930 - 15,375 removed principal & interest leaving 145,555 nov 20, 2003 nov 20, 2004 6,549 - 152,104 nov 20, 2004 nov 20, 2005 6,844 - 158,948 nov 20, 2005 nov 20, 2006 7,152 - 166,100 nov 20, 2006 nov 20, 2007 7,474 - 173,574 nov 20, 2007 nov 20, 2008 7,810 - 181,384 nov 20, 2008 nov 20, 2009 8,162 - 189,546 nov 20, 2009 nov 20, 2010 8,529 - 198,075 nov 20, 2010 nov 20, 2011 8,913 - 206,988 nov 20, 2011 nov 20, 2012 9,314 - 216,302 nov 20, 2012 nov 20, 2013 9,733 - 226,035 nov 20, 2013 nov 20, 2014 10,171 - 236,206 nov 20, 2014 nov 20, 2015 10,629 - 257,942 nov 20, 2015 nov 20, 2016 11,107 - 246,835 nov 20, 2016 nov 20, 2017 11,607 - 269,549 principal paid 269,549-145,555=123,994 nov 20, 2017 nov 20, 2018 5,579 - 129,573 nov 20, 2018 nov 20, 2019 5,830 - 135,403 nov 20, 2019 nov 20, 2020 6,093 - 141,496 nov 20, 2020 nov 20, 2021 6,367 - 147,863 nov 20, 2021 nov 20, 2022 6,653 - 154,516 to correct funds for investment 11/30/03 78,671- 233187”

Form 990, Part XI

“Prior year recorded a receivable for erc credit it was received and prior year amended. Recievable and equity were nit adjusted for it.”

Form 990, Part XI, Line 9

“Book / tax depreciation difference 18,532”

Raw XML Appendix345 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0false
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0FRONTIERS IN BIOSCIENCE IA AN ORGANIZATIOJ DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVO;VE IN THESE ACTIVITIES SINCE JAN. 1 1996. FBS HAS PUBLISHED OBER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND REURRANXCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM OF CANCER CELLS IN ORDER TO GAIN AN INSIGHT TO PROVIDE NEW AVENUES FOR TREATMENT. WE USE STEM CELLS AS WELL AS SIGNALING MOLECULES TO ACHEIVE THE THERAPEUTIC END.
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt08522
IRS990/AllOtherExpensesGrp/ProgramServicesAmt017339
IRS990/AllOtherExpensesGrp/TotalAmt025861
IRS990/BackupWthldComplianceInd0false
IRS990/BooksInCareOfDetail/PersonNm0SIAMAK TABIBZADEH MD
IRS990/BooksInCareOfDetail/PhoneNum09497158286
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt020 SUNSET COVE
IRS990/BooksInCareOfDetail/USAddress/CityNm0NEWPORT COAST
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd092657
IRS990/BusinessRlnWith35CtrlEntInd0false
IRS990/BusinessRlnWithFamMemInd0false
IRS990/BusinessRlnWithOrgMemInd0false
IRS990/CashNonInterestBearingGrp/BOYAmt0137036
IRS990/CashNonInterestBearingGrp/EOYAmt086834
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CollectionsOfArtInd0false
IRS990/CompDisqualPersonsGrp/FundraisingAmt08800
IRS990/CompDisqualPersonsGrp/ManagementAndGeneralAmt08800
IRS990/CompDisqualPersonsGrp/ProgramServicesAmt070400
IRS990/CompDisqualPersonsGrp/TotalAmt088000
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0false
IRS990/CompensationProcessOtherInd0false
IRS990/ConflictOfInterestPolicyInd0false
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0false
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt00
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt048570
IRS990/CYOtherExpensesAmt0227519
IRS990/CYOtherRevenueAmt0131176
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0-214935
IRS990/CYSalariesCompEmpBnftPaidAmt0167162
IRS990/CYTotalExpensesAmt0394681
IRS990/CYTotalFundraisingExpenseAmt09566
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt0179746
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/DepreciationDepletionGrp/ProgramServicesAmt054671
IRS990/DepreciationDepletionGrp/TotalAmt054671
IRS990/Desc0FOSTERING SCIENCE, RESEARCH AND TEACHING IN THE AREAS OF MEDICINE, BIOLOGY,CANCER AND AGING.
IRS990/DescribedInSection501c3Ind0true
IRS990/DisregardedEntityInd0false
IRS990/DocumentRetentionPolicyInd0false
IRS990/DonorAdvisedFundInd0false
IRS990/DonorRstrOrQuasiEndowmentsInd0false
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt03
IRS990/EmploymentTaxReturnsFiledInd0true
IRS990/EngagedInExcessBenefitTransInd0false
IRS990/ExpenseAmt0279531
IRS990/FamilyOrBusinessRlnInd0false
IRS990/FeesForServicesAccountingGrp/ProgramServicesAmt0950
IRS990/FeesForServicesAccountingGrp/TotalAmt0950
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt0695
IRS990/FeesForServicesLegalGrp/TotalAmt0695
IRS990/ForeignActivitiesInd0false
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignOfficeInd0false
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/PersonNm0SIAMAK TABIBZADEH MD
IRS990/Form990PartVIISectionAGrp/PersonNm1SHILA ROOFIM
IRS990/Form990PartVIISectionAGrp/PersonNm2FOROUGH SOOFERIAN
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/TitleTxt0CEO
IRS990/Form990PartVIISectionAGrp/TitleTxt1CFO
IRS990/Form990PartVIISectionAGrp/TitleTxt2SEC
IRS990/Form990ProvidedToGvrnBodyInd0false
IRS990/Form990TFiledInd0true
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedInd0false
IRS990/FundraisingActivitiesInd0false
IRS990/GamingActivitiesInd0false
IRS990/GoverningBodyVotingMembersCnt03
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0false
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossReceiptsAmt0316523
IRS990/GrossRentsGrp/RealAmt0267757
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0false
IRS990/IndependentAuditFinclStmtInd0false
IRS990/IndependentVotingMemberCnt00
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIInd0X
IRS990/InsuranceGrp/ProgramServicesAmt090
IRS990/InsuranceGrp/TotalAmt090
IRS990/InterestGrp/ManagementAndGeneralAmt0211
IRS990/InterestGrp/TotalAmt0211
IRS990/InvestmentIncomeGrp/RelatedOrExemptFuncIncomeAmt048570
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt048570
IRS990/InvestmentInJointVentureInd0false
IRS990/InvestmentsPubTradedSecGrp/BOYAmt05481
IRS990/InvestmentsPubTradedSecGrp/EOYAmt05484
IRS990/IRPDocumentCnt00
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt01446342
IRS990/LandBldgEquipBasisNetGrp/BOYAmt05810376
IRS990/LandBldgEquipBasisNetGrp/EOYAmt05701157
IRS990/LandBldgEquipCostOrOtherBssAmt07147499
IRS990/LessRentalExpensesGrp/RealAmt0136777
IRS990/LoanOutstandingInd0false
IRS990/LoansFromOfficersDirectorsGrp/BOYAmt0233187
IRS990/LoansFromOfficersDirectorsGrp/EOYAmt0233187
IRS990/LobbyingActivitiesInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd0true
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0FRONTIERS IN BIOSCIENCE IA AN ORGANIZATIOJ DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVO;VE IN THESE ACTIVITIES SINCE JAN. 1 1996. FBS HAS PUBLISHED OBER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND REURRANXCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM OF CANCER CELLS IN ORDER TO GAIN AN INSIGHT TO PROVIDE NEW AVENUES FOR TREATMENT. WE USE STEM CELLS AS WELL AS SIGNALING MOLECULES TO ACHEIVE THE THERAPEUTIC END.
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0false
IRS990/NetAssetsOrFundBalancesBOYAmt08903211
IRS990/NetAssetsOrFundBalancesEOYAmt08730956
IRS990/NetRentalIncomeOrLossGrp/TotalRevenueColumnAmt0130980
IRS990/NetRentalIncomeOrLossGrp/UnrelatedBusinessRevenueAmt0130980
IRS990/NetUnrelatedBusTxblIncmAmt0129980
IRS990/NetUnrlzdGainsLossesInvstAmt084680
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt08903211
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt08730956
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NondeductibleContributionsInd0false
IRS990/OfficerMailingAddressInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt042000
IRS990/OtherChangesInNetAssetsAmt0-42000
IRS990/OtherExpensesGrp/Desc0FEDERAL TAXES
IRS990/OtherExpensesGrp/Desc1PROPERTY TAXES
IRS990/OtherExpensesGrp/Desc2STATE TAXES
IRS990/OtherExpensesGrp/Desc3UTILITIES
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt064594
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt121996
IRS990/OtherExpensesGrp/ProgramServicesAmt045581
IRS990/OtherExpensesGrp/ProgramServicesAmt112870
IRS990/OtherExpensesGrp/TotalAmt064594
IRS990/OtherExpensesGrp/TotalAmt145581
IRS990/OtherExpensesGrp/TotalAmt221996
IRS990/OtherExpensesGrp/TotalAmt312870
IRS990/OtherLiabilitiesGrp/BOYAmt010861
IRS990/OtherLiabilitiesGrp/EOYAmt013275
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt066922
IRS990/OtherSalariesAndWagesGrp/TotalAmt066922
IRS990/PartialLiquidationInd0false
IRS990/PayrollTaxesGrp/FundraisingAmt0766
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt0766
IRS990/PayrollTaxesGrp/ProgramServicesAmt010708
IRS990/PayrollTaxesGrp/TotalAmt012240
IRS990/PoliticalCampaignActyInd0false
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt06045
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt04372
IRS990/PrincipalOfficerNm0SIAMAK TABIBZADEH MD
IRS990/ProfessionalFundraisingInd0false
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYExcessBenefitTransInd0false
IRS990/PYInvestmentIncomeAmt02882
IRS990/PYOtherExpensesAmt0153068
IRS990/PYOtherRevenueAmt0156301
IRS990/PYRevenuesLessExpensesAmt0-175368
IRS990/PYSalariesCompEmpBnftPaidAmt0181483
IRS990/PYTotalExpensesAmt0334551
IRS990/PYTotalRevenueAmt0159183
IRS990/ReconcilationRevenueExpnssAmt0-214935
IRS990/RelatedEntityInd0false
IRS990/RelatedOrganizationCtrlEntInd0false
IRS990/RentalIncomeOrLossGrp/RealAmt0130980
IRS990/ReportInvestmentsOtherSecInd0false
IRS990/ReportLandBuildingEquipmentInd0true
IRS990/ReportOtherAssetsInd0false
IRS990/ReportOtherLiabilitiesInd0true
IRS990/ReportProgramRelatedInvstInd0false
IRS990/RoyaltiesRevenueGrp/RelatedOrExemptFuncIncomeAmt0196
IRS990/RoyaltiesRevenueGrp/TotalRevenueColumnAmt0196
IRS990/SavingsAndTempCashInvstGrp/BOYAmt03146321
IRS990/SavingsAndTempCashInvstGrp/EOYAmt03179571
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt09394
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt09394
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus1YearAmt024
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus2YearsAmt0486
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus3YearsAmt027615
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus4YearsAmt08428
IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt036553
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt048766
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt05664
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt0155032
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt0147977
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus4YearsAmt0286789
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt0644228
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus1YearAmt024
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus2YearsAmt0486
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus3YearsAmt027615
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus4YearsAmt08428
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt036553
IRS990ScheduleA/InvestmentIncomeCYPct00.03000
IRS990ScheduleA/InvestmentIncomePYPct00.04000
IRS990ScheduleA/NetIncomeFromOtherUBIGrp/CurrentTaxYearAmt0129980
IRS990ScheduleA/NetIncomeFromOtherUBIGrp/CurrentTaxYearMinus1YearAmt0152495
IRS990ScheduleA/NetIncomeFromOtherUBIGrp/CurrentTaxYearMinus2YearsAmt086919
IRS990ScheduleA/NetIncomeFromOtherUBIGrp/TotalAmt0369394
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct00.61690
IRS990ScheduleA/PublicSupportPY509Pct00.67300
IRS990ScheduleA/PublicSupportTotal509Amt0653622
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt048766
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt05664
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt0164426
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt0147977
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt0286789
IRS990ScheduleA/Total509Grp/TotalAmt0653622
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt0178746
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt0158183
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt0251831
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt0175592
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt0295217
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt01059569
IRS990/ScheduleBRequiredInd0false
IRS990ScheduleD/BuildingsGrp/BookValueAmt02496646
IRS990ScheduleD/BuildingsGrp/DepreciationAmt01006507
IRS990ScheduleD/BuildingsGrp/OtherCostOrOtherBasisAmt03503153
IRS990ScheduleD/LandGrp/BookValueAmt03229805
IRS990ScheduleD/LandGrp/OtherCostOrOtherBasisAmt03229805
IRS990ScheduleD/OtherLandBuildingsGrp/BookValueAmt0-25294
IRS990ScheduleD/OtherLandBuildingsGrp/DepreciationAmt0439835
IRS990ScheduleD/OtherLandBuildingsGrp/OtherCostOrOtherBasisAmt0414541
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt08290
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt14985
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc0TENANT DEPOSITS
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc1CREDIT CARD/ PAYROLL TAXES
IRS990ScheduleD/TotalBookValueLandBuildingsAmt05701157
IRS990ScheduleD/TotalLiabilityAmt013275
IRS990/ScheduleJRequiredInd0false
IRS990/ScheduleORequiredInd0false
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0FRONTIERS IN BIOSCIENCE IA AN ORGANIZATIOJ DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVO;VE IN THESE ACTIVITIES SINCE JAN. 1 1996. FBS HAS PUBLISHED OBER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND REURRANXCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM OF CANCER CELLS IN ORDER TO GAIN AN INSIGHT TO PROVIDE NEW AVENUES FOR TREATMENT. WE USE STEM CELLS AS WELL AS SIGNALING MOLECULES TO ACHEIVE THE THERAPEUTIC END.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1SEE ATTACHMENT NOVEMBER 20, 2022 PART IV, LINE 63, LOANS FROM OFFICERS, DIRECTOR AND EMPLOYEE ON NOVEMBER 20, 2002, FRONTIERS IN BIOSCIENCE, INC. PURCHASED FOR INVESTMENT PURPOSES ONLY RESIDENTIAL REAL ESTATE LOCATED AT 67 PARKVIEW DRIVE, SEARINGTOWN, NEW YORK. IN CONNECTION WITH THE ORGANIZATION'S PURCHASE OF SAID REAL ESTATE, FRONTIERS IN BIOSCIENCE INC., INCURRED A MORTGAGE PAYABLE WITH THE PRESIDEN AND FOUNDER, SIAMAK TABIBZADEH, MD, IN THE AMOUNT OF 145,000 LENDER'S NAME: SIAMAK TABIBZADEH, MD ORIGINAL AMOUNT OF NOTE: 154,000 BALANCE DUE: 145,555 DATE OF NOTE: NOVEMBER 20, 2002 MATURITY DATE: OPEN, SEE BELOW REPAYMENT TERMS: PRINCIPAL AND ACCRUED INTEREST DUE UPON SALE OF PROPERTY INTEREST RETE: RATE OF 4.5% PER ANNUM, PRINCIPAL AND INTEREST DUE UPON SALE OF PROPERTY OR AT SUCH TIME AS THE BOARD OF DIRECTOR DETERMINES THAT THERE ARE SUFFICIENT OPERATING FUNDS TO RETIRE THE OBILIGATION SECURITY PRIOVIDED BY THE BORROWER: MORTGAGE NOTE SECURED BY REAL ESTATE LOCATED AT 67 PARKVIEW DRIVE, SEARINGTOWN, NY 11507 PURPOSE OF THE LOAN: TO BE ABLE TO PURCHASE REAL ESTATE AT BELOW FAIR MARKET VALUE TO SEE IN NO LONGER THAN TWO OPERATING CYCLES IN ORDER TO OBTAIN SUFFICIENT FUNDING TO ENDOW A FULL TIME MEDICAL RESEARCHER AND EDITOR. INTERST CALCUATION ORIGINAL AMOUNT OF PRINCIPAL: 154,000 FROM TO INTEREST AMOUNT (RATE, 4.5%) - PRINCIPAL + INTEREST NOV 20, 2002 154,000 NOV 20, 2002 NOV 20, 2003 6,930 - 160,930 - 15,375 REMOVED PRINCIPAL & INTEREST LEAVING 145,555 NOV 20, 2003 NOV 20, 2004 6,549 - 152,104 NOV 20, 2004 NOV 20, 2005 6,844 - 158,948 NOV 20, 2005 NOV 20, 2006 7,152 - 166,100 NOV 20, 2006 NOV 20, 2007 7,474 - 173,574 NOV 20, 2007 NOV 20, 2008 7,810 - 181,384 NOV 20, 2008 NOV 20, 2009 8,162 - 189,546 NOV 20, 2009 NOV 20, 2010 8,529 - 198,075 NOV 20, 2010 NOV 20, 2011 8,913 - 206,988 NOV 20, 2011 NOV 20, 2012 9,314 - 216,302 NOV 20, 2012 NOV 20, 2013 9,733 - 226,035 NOV 20, 2013 NOV 20, 2014 10,171 - 236,206 NOV 20, 2014 NOV 20, 2015 10,629 - 257,942 NOV 20, 2015 NOV 20, 2016 11,107 - 246,835 NOV 20, 2016 NOV 20, 2017 11,607 - 269,549 PRINCIPAL PAID 269,549-145,555=123,994 NOV 20, 2017 NOV 20, 2018 5,579 - 129,573 NOV 20, 2018 NOV 20, 2019 5,830 - 135,403 NOV 20, 2019 NOV 20, 2020 6,093 - 141,496 NOV 20, 2020 NOV 20, 2021 6,367 - 147,863 NOV 20, 2021 NOV 20, 2022 6,653 - 154,516 TO CORRECT FUNDS FOR INVESTMENT 11/30/03 78,671- 233187
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2NO REVIEW WAS OR WILL BE CONDUCTED.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3NO DOCUMENTS AVAILABLE TO THE PUBLIC
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4PRIOR YEAR RECORDED A RECEIVABLE FOR ERC CREDIT IT WAS RECEIVED AND PRIOR YEAR AMENDED. RECIEVABLE AND EQUITY WERE NIT ADJUSTED FOR IT.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5BOOK / TAX DEPRECIATION DIFFERENCE 18,532
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990 - ORGANIZATION'S MISSION
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PAGE 6, PART VI, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990, PAGE 6, PART VI, LINE 19
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990, PART XI
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5FORM 990, PART XI, LINE 9
IRS990/SchoolOperatingInd0false
IRS990/SignificantChangeInd0false
IRS990/SignificantNewProgramSrvcInd0false
IRS990/StatesWhereCopyOfReturnIsFldCd0CA
IRS990/SubjectToExcsTaxNetInvstIncInd0false
IRS990/SubjectToProxyTaxInd0false
IRS990/SubjToTaxRmnrtnExPrchtPymtInd0false
IRS990/TaxablePartyNotificationInd0false
IRS990/TaxExemptBondsInd0false
IRS990/TerminateOperationsInd0false
IRS990/TotalAssetsBOYAmt09147259
IRS990/TotalAssetsEOYAmt08977418
IRS990/TotalAssetsGrp/BOYAmt09147259
IRS990/TotalAssetsGrp/EOYAmt08977418
IRS990/TotalCompGreaterThan150KInd0false
IRS990/TotalEmployeeCnt03
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt09566
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt0105584
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt0279531
IRS990/TotalFunctionalExpensesGrp/TotalAmt0394681
IRS990/TotalGrossUBIAmt0130980
IRS990/TotalLiabilitiesBOYAmt0244048
IRS990/TotalLiabilitiesEOYAmt0246462
IRS990/TotalLiabilitiesGrp/BOYAmt0244048
IRS990/TotalLiabilitiesGrp/EOYAmt0246462
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt08903211
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt08730956
IRS990/TotalProgramServiceExpensesAmt0279531
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt048766
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt0179746
IRS990/TotalRevenueGrp/UnrelatedBusinessRevenueAmt0130980
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt09147259
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt08977418
IRS990/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd0true
IRS990/USAddress/AddressLine1Txt020 SUNSET COVE
IRS990/USAddress/CityNm0NEWPORT COAST
IRS990/USAddress/StateAbbreviationCd0CA
IRS990/USAddress/ZIPCd092657
IRS990/VotingMembersGoverningBodyCnt03
IRS990/VotingMembersIndependentCnt00
IRS990/WebsiteAddressTxt0WWW.BIOSCIENCE.ORG
IRS990/WhistleblowerPolicyInd0false
ReturnHeader/BuildTS02025-03-06 01:10:19Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0SIAMAK TABIBZADEH MD
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0CEO
ReturnHeader/BusinessOfficerGrp/PhoneNum09497158286
ReturnHeader/BusinessOfficerGrp/SignatureDt02026-01-16
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0FRONTIERS IN BIOSCIENCE
ReturnHeader/Filer/BusinessNameControlTxt0FRON
ReturnHeader/Filer/EIN0593432665
ReturnHeader/Filer/PhoneNum09497158286
ReturnHeader/Filer/USAddress/AddressLine1Txt020 SUNSET COVE
ReturnHeader/Filer/USAddress/CityNm0NEWPORT COAST
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd092657
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0330990695
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0LGH CONSULTING INC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0585 S STATE COLLEGE BLVD
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0ANAHEIM
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0CA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0928064222
ReturnHeader/PreparerPersonGrp/PhoneNum07148089170
ReturnHeader/PreparerPersonGrp/PreparationDt02026-02-26
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0GEORGE HUKRIEDE
ReturnHeader/ReturnTs02026-02-26T11:40:20-05:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/TaxPeriodBeginDt02025-01-01
ReturnHeader/TaxPeriodEndDt02025-12-31
ReturnHeader/TaxYr02025

Document Assets

No mirrored PDF or thumbnail assets are attached yet.